Tag: GSK
Arzneimittelhersteller Stada sucht neuen Investor
Stada-Zentrale in Bad Vilbel bei Frankfurt Bei einem Deal könnte Stada mit zehn Milliarden Euro oder mehr bewertet werden. (Foto: Reuters) Frankfurt Beim hessischen Arzneimittelhersteller Stada könnte sich Unternehmenskreisen zufolge bald…
Morphosys: Biotech pioneer in the crisis of confidence
Medical research (icon image) Morphosys share price still fails to recover. (Photo: IMAGO/Westend61) Frankfurt After failures at research partners and disappointing sales figures for its first own drug, the Munich…
The flu wave is coming – but only a few are vaccinated
Frankfurt The number of flu infections in Germany is increasing – according to the Robert Koch Institute (RKI), the flu wave began in Germany at the end of October. Before…
Sales growth due to Corona will probably drop soon
Frankfurt The corona pandemic is causing enormous sales increases in the pharmaceutical industry: In 2021 and 2022, companies will generate sales of up to 200 billion dollars outside of normal…
Sanofi, GSK, Boehringer Ingelheim: Investors fear wave of lawsuits
Stomach medication Zantac Several pharmaceutical companies are threatened with lawsuits in the USA because of possible carcinogenic ingredients. (Photo: Reuters) Frankfurt A stomach medicine that has been banned from the…
Big Pharma is boosting the blockbuster business with spin-offs
Frankfurt The pharmaceutical industry is in the middle of a profound structural change. The leading companies in the industry are increasingly specializing in drug production. And part with fringe activities…
Corona vaccine from Sanofi and GSK is about to be approved
Vaccine from Sanofi and GSK With their vaccine, the pharmaceutical companies would only be number six in the largely divided market. (Photo: Reuters) Frankfurt After positive study data, the pharmaceutical…
Corona boom brings record growth to pharmaceutical industry
Frankfurt In 2021, the corona pandemic gave the pharmaceutical industry the biggest jump in sales in decades. Overall, the industry generated additional sales of almost $100 billion last year with…
Unilever grows stronger – but margin outlook “shocking”
Dusseldorf The one under pressure Consumer goods group Unilever is excluding major acquisitions for the time being. “We are not aiming for any major acquisitions in the foreseeable future,” said…
Why Unilever wants to take over part of GSK
Dusseldorf, London It could be the largest transaction since the outbreak of the pandemic: the British group Unilever wants to take over the consumer goods division of the pharmaceutical giant…